Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Articles|January 12, 2010
To Minimize SkinConcerns-Magnify!
Having a magnifying mirror availablein each examination roommakes it easier for both patients andphysicians to identify facial lesions.
Advertisement
Having a magnifying mirror available in each examination room makes it easier for both patients and physicians to identify facial lesions. Readily available magnifying mirrors can also obviate treatment of the wrong lesion.
-- Benjamin Barankin, MD
Toronto
Would you find this Pointer helpful in your practice?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
Sentinel Antibodies May Identify Patients With Blunted Vaccine Responses
5